title: Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants.
abstract: Maternal smoking is a recognized risk factor for orofacial clefts. Maternal or fetal pharmacogenetic variants are plausible modulators of this risk. In this work, we studied 5,427 DNA samples, including 1,244 from subjects in Denmark and Iowa with facial clefting and 4,183 from parents, siblings, or unrelated population controls. We examined 25 single-nucleotide polymorphisms in 16 genes in pathways for detoxification of components of cigarette smoke, to look for evidence of gene-environment interactions. For genes identified as related to oral clefting, we studied gene-expression profiles in fetal development in the relevant tissues and time intervals. Maternal smoking was a significant risk factor for clefting and showed dosage effects, in both the Danish and Iowan data. Suggestive effects of variants in the fetal NAT2 and CYP1A1 genes were observed in both the Iowan and the Danish participants. In an expanded case set, NAT2 continued to show significant overtransmission of an allele to the fetus, with a final P value of .00003. There was an interaction between maternal smoking and fetal inheritance of a GSTT1-null deletion, seen in both the Danish (P=.03) and Iowan (P=.002) studies, with a Fisher's combined P value of <.001, which remained significant after correction for multiple comparisons. Gene-expression analysis demonstrated expression of GSTT1 in human embryonic craniofacial tissues during the relevant developmental interval. This study benefited from two large samples, involving independent populations, that provided substantial power and a framework for future studies that could identify a susceptible population for preventive health care.
authors.affiliation: Department of Biology, University of Iowa, Iowa City, IA, 52242, USA.
authors.forename: Min
authors.initials: M
authors.lastname: Shi
authors.forename: Kaare
authors.initials: K
authors.lastname: Christensen
authors.forename: Clarice R
authors.initials: CR
authors.lastname: Weinberg
authors.forename: Paul
authors.initials: P
authors.lastname: Romitti
authors.forename: Lise
authors.initials: L
authors.lastname: Bathum
authors.forename: Anthony
authors.initials: A
authors.lastname: Lozada
authors.forename: Richard W
authors.initials: RW
authors.lastname: Morris
authors.forename: Michael
authors.initials: M
authors.lastname: Lovett
authors.forename: Jeffrey C
authors.initials: JC
authors.lastname: Murray
mesh_terms: D001191:Arylamine N-Acetyltransferase / Q000096:biosynthesis / Q000235:genetics*; D002971:Cleft Lip / Q000235:genetics*; D002972:Cleft Palate / Q000235:genetics*; D019363:Cytochrome P-450 CYP1A1 / Q000096:biosynthesis / Q000235:genetics*; D004622:Embryo, Mammalian / Q000378:metabolism; D005260:Female; D020869:Gene Expression Profiling; D005982:Glutathione Transferase / Q000235:genetics*; D049669:History, 16th Century; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D018811:Maternal Exposure / Q000009:adverse effects*; D020641:Polymorphism, Single Nucleotide; D011247:Pregnancy; D012307:Risk Factors; D012907:Smoking / Q000235:genetics*
chemical_list: D019363:Cytochrome P-450 CYP1A1; D001191:Arylamine N-Acetyltransferase; C478900:NAT2 protein, human; C413545:glutathione S-transferase T1; D005982:Glutathione Transferase